Friday, May 29, 2015

Blood Cancer Journal - Table of Contents alert Volume 5 May 2015

If you are unable to see the message below, click here to view.
Blood Cancer Journal

TABLE OF CONTENTS

Volume 5, May 2015

In this issue
Original Articles
Letters to the Editor
Letters to the Editor
Sign up for e-alerts Sign up for e-alerts
Web feed

Original Articles

Top

NPM-ALK mediates phosphorylation of MSH2 at tyrosine 238, creating a functional deficiency in MSH2 and the loss of mismatch repair

K M Bone, P Wang, F Wu, C Wu, L Li, J T Bacani, S E Andrew and R Lai

Blood Cancer J 2015 5: e311; 10.1038/bcj.2015.35

Abstract | Full Text

Rational combination treatment with histone deacetylase inhibitors and immunomodulatory drugs in multiple myeloma

T Hideshima, F Cottini, H Ohguchi, J Jakubikova, G Gorgun, N Mimura, Y-T Tai, N C Munshi, P G Richardson and K C Anderson

Blood Cancer J 2015 5: e312; 10.1038/bcj.2015.38

Abstract | Full Text

A novel antibody–drug conjugate targeting SAIL for the treatment of hematologic malignancies

S Y Kim, J-W Theunissen, J Balibalos, S Liao-Chan, M C Babcock, T Wong, B Cairns, D Gonzalez, E H van der Horst, M Perez, Z Levashova, L Chinn, J A D‘Alessio, M Flory, A Bermudez, D Y Jackson, E Ha, J Monteon, M F Bruhns, G Chen and T-S Migone

Blood Cancer J 2015 5: e316; 10.1038/bcj.2015.39

Abstract | Full Text

The SUV39H1 inhibitor chaetocin induces differentiation and shows synergistic cytotoxicity with other epigenetic drugs in acute myeloid leukemia cells

Y-S Lai, J-Y Chen, H-J Tsai, T-Y Chen and W-C Hung

Blood Cancer J 2015 5: e313; 10.1038/bcj.2015.37

Abstract | Full Text

Novel drug candidates for blast phase chronic myeloid leukemia from high-throughput drug sensitivity and resistance testing

P O Pietarinen, T Pemovska, M Kontro, B Yadav, J P Mpindi, E I Andersson, M M Majumder, H Kuusanmäki, P Koskenvesa, O Kallioniemi, K Wennerberg, C A Heckman, S Mustjoki and K Porkka

Blood Cancer J 2015 5: e309; 10.1038/bcj.2015.30

Abstract | Full Text

Abnormal FISH in patients with immunoglobulin light chain amyloidosis is a risk factor for cardiac involvement and for death

R Warsame, S K Kumar, M A Gertz, M Q Lacy, F K Buadi, S R Hayman, N Leung, D Dingli, J A Lust, R P Ketterling, Y Lin, S Russell, L Hwa, P Kapoor, R S Go, S R Zeldenrust, R A Kyle, S V Rajkumar and A Dispenzieri

Blood Cancer J 2015 5: e310; 10.1038/bcj.2015.34

Abstract | Full Text

Letters to the Editor

Top

A novel MYD88 mutation, L265RPP, in Waldenström macroglobulinemia activates the NF-κB pathway to upregulate Bcl-xL expression and enhances cell survival

T Nagao, G Oshikawa, S Ishida, H Akiyama, Y Umezawa, A Nogami, T Kurosu and O Miura

Blood Cancer J 2015 5: e314; 10.1038/bcj.2015.36

Full Text

Letters to the Editor

Top

ASXL1 mutated chronic myelomonocytic leukemia in a patient with familial thrombocytopenia secondary to germline mutation in ANKRD26

J Perez Botero, J L Oliveira, D Chen, K K Reichard, D S Viswanatha, P L Nguyen, R K Pruthi, J Majerus, P Gada, N Gangat, A Tefferi and M M Patnaik

Blood Cancer J 2015 5: e315; 10.1038/bcj.2015.41

Full Text

Investigation of potential traces of pluripotency in germinal-center-derived B-cell lymphomas driven by MYC

R Wagener, M Lenz, B Schuldt, I Lenz, A Schuppert, R Siebert and F-J Müller

Blood Cancer J 2015 5: e317; 10.1038/bcj.2015.40

Full Text

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: